/clinical/,/clinical/cckm-tools/,/clinical/cckm-tools/content/,/clinical/cckm-tools/content/beacon-protocols/,/clinical/cckm-tools/content/beacon-protocols/supportive-care/,

/clinical/cckm-tools/content/beacon-protocols/supportive-care/name-122940-en.cckm

201711331

page

100

UWHC,UWMF,

Tools,

Clinical Hub,UW Health Clinical Tool Search,UW Health Clinical Tool Search,Beacon Protocols,Supportive Care

CSC SC Fulvestrant (Faslodex) 500 mg D1,15 and 29 then 500 mg Monthly Ver 11-20-17 (HL 1856)

CSC SC Fulvestrant (Faslodex) 500 mg D1,15 and 29 then 500 mg Monthly Ver 11-20-17 (HL 1856) - Clinical Hub, UW Health Clinical Tool Search, UW Health Clinical Tool Search, Beacon Protocols, Supportive Care


CSC SC FULVESTRANT (FASLODEX): 500 MG D1,15 AND 29 THEN 500 MG MONTHLY VER: 11-20-
17 –  Properties
Cycle 1 –  11/22/2017 through 1/16/2018 (56 days), Planned
Day 1, Cycle 1 –  Planned for 11/22/2017
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Day 15, Cycle 1 –  Planned for 12/6/2017
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Day 29, Cycle 1 –  Planned for 12/20/2017
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Cycle 2 –  1/17/2018 through 2/13/2018 (28 days), Planned
Day 1, Cycle 2 –  Planned for 1/17/2018
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Cycle 3 –  2/14/2018 through 3/13/2018 (28 days), Planned
Day 1, Cycle 3 –  Planned for 2/14/2018
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Cycle 4 –  3/14/2018 through 4/10/2018 (28 days), Planned
Day 1, Cycle 4 –  Planned for 3/14/2018
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
ZZtestonc,Andrew [2428787]
11/22/2017 11:57:50 AM Page 1 of 2
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised: 11/2017CCKM@uwhealth.org

250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Cycle 5 –  4/11/2018 through 5/8/2018 (28 days), Planned
Day 1, Cycle 5 –  Planned for 4/11/2018
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Cycle 6 –  5/9/2018 through 6/5/2018 (28 days), Planned
Day 1, Cycle 6 –  Planned for 5/9/2018
Supportive Care Medications
fulvestrant (FASLODEX) injection 250 mg
250 mg, Intramuscular, EVERY 5 MINUTES, 2 doses Starting when released
Total dose = 500 mg (2 syringes)
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
ZZtestonc,Andrew [2428787]
11/22/2017 11:57:50 AM Page 2 of 2
Copyright © 2017 University of Wisconsin Hospitals and Clinics Authority
Contact: Lee Vermeulen, CCKM@uwhealth.org Last Revised:
 
11/2017CCKM@uwhealth.org